Oxford Nanopore Technologies plc is a UK-based company that has developed and commercialises a new generation of DNA/RNA sequencing technology. Their proprietary nanopore-based platform offers real-time, scalable, and portable sequencing solutions, impacting various fields including genomic research, clinical diagnostics, agriculture, and environmental science. The company aims to enable the analysis of anything, by anyone, anywhere, by making sequencing more accessible and versatile. Their technology allows for direct sequencing of native DNA/RNA, long reads, and rapid data delivery, empowering scientists and clinicians worldwide.
Serves as the global R&D hub, corporate headquarters, and a key manufacturing site, driving innovation in nanopore sequencing technology and global operations.
State-of-the-art laboratories, advanced manufacturing facilities for flow cells and sequencing devices, located within the prestigious Oxford Science Park, fostering collaboration and innovation.
A dynamic, fast-paced, and innovative environment focused on cutting-edge scientific research and development. Emphasizes collaboration, intellectual curiosity, and a mission-driven approach to making sequencing technology universally accessible.
Central to the company's pioneering work in nanopore sequencing, acting as the nerve center for research, product development, and strategic decision-making that shapes the future of genomics.
Oxford Nanopore Technologies supports its global customer base through a network of direct sales and support teams, and distributors across the Americas, Europe, Middle East, Africa (EMEA), and Asia-Pacific (APAC). Key functions supported globally include research and development (primarily UK), advanced manufacturing (UK), commercial operations (sales, marketing, application support), customer service, and logistics to ensure worldwide access to their sequencing platforms and consumables.
Gosling Building, Edmund Cartwright Avenue, Oxford Science Park
Oxford
Oxfordshire
United Kingdom
Address: 701 Gateway Boulevard, Suite 400, South San Francisco, CA 94080, USA
To drive adoption of nanopore sequencing technology across the Americas, provide localized support to a large customer base, and foster collaborations with leading research institutions and companies.
Address: Unit 1001-1002, 10F, Building T1, No.2889, Jinke Road, Pudong New Area, Shanghai, China
To expand market presence, cater to specific regional needs in genomics research and applications, and build strong relationships with local scientific communities and commercial partners in China.
Address: Zephyr Building, Eighth Street, Harwell Science and Innovation Campus, Didcot, OX11 0RL, United Kingdom
To ensure scalable, high-quality production of key proprietary consumables, supporting global demand and underpinning the accessibility of Oxford Nanopore's sequencing platforms.
Address: 25 First Street, Suite 103, Cambridge, MA 02141, USA
To strengthen market penetration and provide tailored support to key customers and research partners in the Eastern United States.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Oxford Nanopore Technologies' leadership includes:
Oxford Nanopore Technologies has been backed by several prominent investors over the years, including:
The primary executive team change in the last 12 months involved the Chief Technology Officer position. Dr. Clive G. Brown stepped down, and Spike Bucklow, previously VP of Technology, was appointed as Acting CTO, reflecting a strategic transition within the company's technology leadership.
Discover the tools Oxford Nanopore Technologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Oxford Nanopore Technologies primarily uses a standard corporate email format based on employee names. The most common structure is [first_name].[last_name]@nanoporetech.com. This format is widely adopted for professional communication within and outside the company.
first.last@nanoporetech.com
Format
jane.doe@nanoporetech.com
Example
90%
Success rate
Oxford Nanopore Technologies PLC / London Stock Exchange • April 25, 2024
Oxford Nanopore Technologies announced its Q1 2024 trading update, highlighting Life Science Research Tools (LSRT) revenue of £42.8 million, up 17% year-on-year (18% CER). The company reiterated its full-year 2024 LSRT revenue guidance of 10-20% growth (CER)....more
Oxford Nanopore Technologies PLC / Regulatory News Service (RNS) • May 15, 2024
Oxford Nanopore Technologies announced that Dr. Clive G. Brown will step down as Chief Technology Officer and from the Board, effective May 15, 2024. He will transition to a consultant role for the company. Spike Bucklow, VP of Technology, has been appointed as Acting Chief Technology Officer....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Oxford Nanopore Technologies, are just a search away.